| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/13/2013 | CN101965410B System and method for improved processing of nucleic acids for production of sequencable libraries |
| 03/13/2013 | CN101962681B Gene chip for detecting genuine coptis medicinal materials |
| 03/13/2013 | CN101946850B Lactobacillus reuteri fermented liquid feed, preparation method and application thereof |
| 03/13/2013 | CN101851675B Probe set of inspection and quarantine fruit fly and inspection method thereof |
| 03/13/2013 | CN101775436B Method for detecting bovine and sheep derived ingredients in feed and kit |
| 03/13/2013 | CN101768214B Human tumor marker-Tim17 polypeptide and application thereof |
| 03/13/2013 | CN101724693B Primer pair for detecting nested PCR mycoplasmas, detection kit and use method thereof |
| 03/13/2013 | CN101724295B LE Green mixed dye and applications thereof |
| 03/13/2013 | CN101717815B Legionnella rapid detecting and parting method |
| 03/13/2013 | CN101702920B Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease |
| 03/13/2013 | CN101522888B Microbial cell culture medium, and microbial cell culture method |
| 03/13/2013 | CN101384716B HLA-a*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 03/13/2013 | CN101339153B Labelling foodstuff pathogenic bacteria growth checking method |
| 03/13/2013 | CN101336290B Bioreactor for cell and tissue culture |
| 03/13/2013 | CN101292046B Assay for a health state |
| 03/13/2013 | CN101281200B Immunoassay method, reagent kit for detecting alkaline phosphatase, and reagent kit for immunoassay |
| 03/13/2013 | CN101280343B Primer for quantitative and qualitative determination of blue tongue virus |
| 03/13/2013 | CN101245312B Method of monitoring microbiological activity in process streams |
| 03/13/2013 | CN101203618B Isothermal strand displacement amplification using primers containing a non-regular base |
| 03/13/2013 | CN101134779B Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/12/2013 | US8396673 Gene assaying method, gene assaying program, and gene assaying device |
| 03/12/2013 | US8394949 Multisignal labeling reagents, and processes and uses therefor |
| 03/12/2013 | US8394947 has a plurality of modified ribofuranosyl nucleosides at defined locations; comprise double stranded constructs wherein one of the strands capable of hybridizing to a nucleic acid target |
| 03/12/2013 | US8394946 Multicomponent nucleic acid enzymes and methods for their use |
| 03/12/2013 | US8394945 Compositions for use in identification of bacteria |
| 03/12/2013 | US8394944 for detection and quantitation of single nucleotide polymorphisms (SNPs) using polymerase chain reaction (PCR); kits |
| 03/12/2013 | US8394932 Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394929 Nogo receptor-mediated blockade of axonal growth |
| 03/12/2013 | US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/12/2013 | US8394756 Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells |
| 03/12/2013 | US8394640 Study of polymer molecules and conformations with a nanopore |
| 03/12/2013 | US8394639 Biomarkers for renal disease |
| 03/12/2013 | US8394628 RNA sequence-specific mediators of RNA interference |
| 03/12/2013 | US8394615 Glucose dehydrogenase |
| 03/12/2013 | US8394609 Primers and methods for the detection and discrimination of nucleic acids |
| 03/12/2013 | US8394603 Codon-optimized nucleic acid for coding apo-clytin-II and method for using the same |
| 03/12/2013 | US8394602 Luminescent method for measuring endotoxin |
| 03/12/2013 | US8394599 Methods and compositions for risk stratification |
| 03/12/2013 | US8394598 Tyrosine kinome |
| 03/12/2013 | US8394593 Use of an IL-12 receptor splice variant and molecular assay to quantify expression thereof |
| 03/12/2013 | US8394592 Methods for assessing cancer susceptibility to carcinogens in tobacco products |
| 03/12/2013 | US8394591 Method for the identification of the clonal source of a restriction fragment |
| 03/12/2013 | US8394590 Capture agents and related methods and systems for detecting and/or sorting targets |
| 03/12/2013 | US8394589 Methods for diagnosing scapuloperoneal spinal muscular atrophy or Charcot-Marie-Tooth disease type 2C by detecting mutations in TRPV4 |
| 03/12/2013 | US8394588 Methods to fix and detect nucleic acids |
| 03/12/2013 | US8394587 Single nucleotide polymorphisms and use of same predicting male-specific prenatal loss |
| 03/12/2013 | US8394586 Labelled nucleotides |
| 03/12/2013 | US8394585 DNA methylation detection methods |
| 03/12/2013 | US8394584 Detecting and sorting methylated DNA using a synthetic nanopore |
| 03/12/2013 | US8394583 VH4 codon signature for multiple sclerosis |
| 03/12/2013 | US8394582 Identification of fetal DNA and fetal cell markers in maternal plasma or serum |
| 03/12/2013 | US8394581 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 03/12/2013 | US8394580 Protein markers for the detection of thyroid cancer metastasis |
| 03/12/2013 | US8394386 Sequential oral, intranasal, or intramuscular administration of a replication-defective adenovirus comprising a first heterologous expression cassette, and an adeno-associated virus comprising a second heterologous expression cassette; side effect reduction in vaccine carriers |
| 03/12/2013 | US8394385 Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against recombinant antigen in MVA vaccines |
| 03/12/2013 | US8394384 Recombinant avian influenza vaccine and uses thereof |
| 03/12/2013 | US8394373 Disintegrin and metalloproteinase containing thrombospondin 1-like domains (ADAMTS); ADAMTS13 protease and to nucleic acids encoding ADAMTS13 proteases; von Willebrand bactor cleaving protease activity; treating acquired thrombotic thrombocytopenic purpura; anticoagulant drug development |
| 03/12/2013 | US8394330 Conductive organic sensors, arrays and methods of use |
| 03/12/2013 | US8394324 Microchip large-volume PCR with integrated real-time CE detection |
| 03/12/2013 | CA2789539A1 Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
| 03/12/2013 | CA2706994C Use of eph-b4 and ephrin-a1 for predicting negative physiological response to the treatment with erythropoietin |
| 03/12/2013 | CA2680946C Pim-3 kinase as a target for type 2 diabetes mellitus |
| 03/12/2013 | CA2676842C Methods of releasing sporocysts from oocysts using controlled shear forces |
| 03/12/2013 | CA2607532C Amplification and cloning of single dna molecules using rolling circle amplification |
| 03/12/2013 | CA2592204C Nucleic acid diagnostics system and methods |
| 03/12/2013 | CA2509345C Bacterial cell component-unresponsive model mouse |
| 03/12/2013 | CA2492631C Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood |
| 03/12/2013 | CA2468888C Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/12/2013 | CA2464691C Methods and systems for dynamic gene expression profiling |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2437044C Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 03/12/2013 | CA2354599C Binding molecules for human factor viii and factor viii-like proteins |
| 03/12/2013 | CA2331765C Formaldehyde dehydrogenase genes from methylotrophic yeasts |
| 03/12/2013 | CA2295552C Cloned genomes of infectious hepatitis c viruses and uses thereof |
| 03/08/2013 | CA2845395A1 Antibody against colorectal cancer marker |
| 03/07/2013 | WO2013033713A1 System and method for the detection of allergens |
| 03/07/2013 | WO2013033647A2 Apparatus and method for electrical detection of oligonucleotides through pore blockades |
| 03/07/2013 | WO2013033640A1 Methods and compositions for detecting cancer based on mirna expression profiles |
| 03/07/2013 | WO2013033636A2 Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same |
| 03/07/2013 | WO2013033627A2 Diagnosis and treatment of arthritis using epigenetics |
| 03/07/2013 | WO2013033515A1 Compounds and methods for assaying redox state of metabolically active cells and methods for measuring nad(p)/nad(p)h |
| 03/07/2013 | WO2013033380A1 Diagnostic markers |
| 03/07/2013 | WO2013033333A1 Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers |
| 03/07/2013 | WO2013033234A1 Molecular markers associated with aphid resistance in soybean |
| 03/07/2013 | WO2013033221A1 Molecular markers associated with soybean tolerance to low iron growth conditions |
| 03/07/2013 | WO2013033210A1 Methods and compositions for producing capsicum plants with powdery mildew resistance |
| 03/07/2013 | WO2013033169A1 Methods of identifying genomic translocations associated with cancer |
| 03/07/2013 | WO2013033143A2 Molecular markers associated with stem canker resistance in soybean |
| 03/07/2013 | WO2013033074A2 Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use |
| 03/07/2013 | WO2013033073A1 Expression of ets related gene (erg) and phosphatase and tensin homolog (pten) correlates with prostate cancer capsular penetration |
| 03/07/2013 | WO2013033019A1 Methods for determining the integrity of a biological sample |
| 03/07/2013 | WO2013032905A1 Modulating wnt activity by targeting gpr177 |
| 03/07/2013 | WO2013032883A2 Methods of detecting and treating cardiovascular diseases |
| 03/07/2013 | WO2013032538A1 Methods for diagnosing and treating cardiac defects |
| 03/07/2013 | WO2013032242A2 Target non-binding aptamer selection method using graphene and aptamer selected therefrom |
| 03/07/2013 | WO2013031973A1 Method for detecting toxin-producing clostridium difficile |
| 03/07/2013 | WO2013031956A1 NUCLEIC ACID CONSTRUCT INCLUDING NUCLEIC ACID DERIVED FROM GENOTYPE 3a HCV GENOME |
| 03/07/2013 | WO2013031912A1 Substrate and analysis method |
| 03/07/2013 | WO2013031853A1 Method for predicting prognosis of prostate cancer |